A detailed review of all the lot history records pertaining to the relevant stent and delivery system lots showed no issues that were deemed related to the complaint investigation.The lot met the relevant in-process monitoring acceptance criteria.Further information on the case was provided by the relevant veryan sales representatives.In this case the anatomy of the patient was severely tortuous, with a tight bifurcation angle to cross.The physician was aware of the difficulty presented by the patient anatomy, and that the case could cause difficulty for the deployment of the 7x150 mm biomimics 3d device.A cross-over approach was used, and upon initiation of deployment the physician experienced resistance.However, the physician did release the distal stent crown and was able to deploy the majority of the stent length.At this point, the bifurcation hub had been fully retracted to the proximal pin luer, but a small portion of the stent remained in the outer braid of the delivery system.It was highlighted that the physician was not overly concerned about the situation and understood that this scenario is a possibility when deploying longer stents.To complete the deployment the physician manipulated the stent delivery system to free the remaining stent crowns.The stent was deployed successfully.Although the investigation team did not receive any angiographic imaging for review as part of this investigation despite multiple requests, and the device was not returned for analysis, they have concluded that a possible root cause of this complaint is the challenging anatomical condition of the patient.Despite resistance being immediately noted by the physician upon initiation of deployment, the attempt to release the stent was continued.It is important to note that the biomimics 3d stent ifu-3 version 3.0 indicates the following warning statement: "warning: if unexpected resistance is felt at the start of the deployment, do not force the movement of the bifurcation luer; instead carefully withdraw the sds without deploying the stent." the coding has been updated to reflect completion of the investigation.This complaint is not related to a deficiency of the device.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
|